NCT00197782已完成4 期
The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
研究概览
简要总结
To measure the magnitude and persistence of the antibody response to a booster dose of Hib conjugate vaccine given between 9 months and 4 years of age to UK children who had completed primary immunisation with 3 doses of Hib vaccine given at 2/3/4 months of age either as a combined D/T/wholecellpertussis/Hib or D/T/acellularpertussis/Hib vaccine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 9 Months 至 4 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Written informed consent from parent or legal guardian of the infant or child
- •Age >= 9 months and <4 years at recruitment
- •Eligible to receive a single dose of Hib vaccine as per the UK schedule
- •Receipt of three doses of Hib vaccine in infancy
排除标准
- •History of Hib infection
- •History of severe local reaction that can be confidently related to a prior Hib immunisation
- •Deferral of vaccination if acute illness and/or temperature >38C on day of vaccination
研究者
Prof. Elizabeth Miller
consultant epidemiologist
Public Health England
相似试验
已完成
3 期
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary VaccinationInfections, MeningococcalNCT01777308GlaxoSmithKline156
已完成
3 期
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 YrsHepatitis BNCT00343915GlaxoSmithKline267
已完成
4 期
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersHepatitis BNCT00240526GlaxoSmithKline79
Unknown
4 期
Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.Japanese Encephalitis VaccineNCT03971058Medical University of Vienna64
已完成
3 期
Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean InfantsDiphtheriaTetanusPertussisPoliomyelitisHepatitis BNCT00303316Sanofi458